|
Holistisk Cancer Behandling och Cancer Psykoterapi Inspirerad av Dr. Fred B. Levenson |
100.00% |
|
Homeopathy as a supportive therapy in cancer. |
70.00% |
|
Homeopatic therapy in Cancer Treatment |
|
|
How to Heal Most Diseases For Less Than One Dollar |
100.00% |
|
How to Heal Most Diseases For Less Than One Dollar |
100.00% |
|
Hypericine |
83.33% |
|
Hyperthermia adds to chemotherapy. |
90.00% |
|
Hyperthermia and Immunity. A Brief Overview |
70.00% |
|
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. |
90.00% |
|
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. |
80.00% |
|
Hypoxia in cancer: significance and impact on clinical outcome. |
70.00% |
|
Hypoxia-inducible factor-1alpha modulation in combination with anti-angiogenic therapy. |
60.00% |
|
Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosp |
50.00% |
|
Ifosfamide, carboplatin, and etoposide (ICE) in combination with regional hyperthermia (RHT) in chemotherapy-pretreated non..... |
40.00% |
|
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, |
50.00% |
|
Immunomodulatory effects of opioids. |
90.00% |
|
Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase. |
60.00% |
|
Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto |
80.00% |
|
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ |
90.00% |
|
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m |
80.00% |
|
Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer..... |
75.00% |
|
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort s |
|
|
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus. |
100.00% |
|
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. |
100.00% |
|
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. |
90.00% |
|
In vitro induction of apoptotic cell death in chronic lymphocytic leukemia by two natural products: preliminary study |
70.00% |
|
In vitro screening for the tumoricidal properties of international medicinal herbs |
80.00% |
|
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. |
90.00% |
|
Increased risk of cancer subsequent to severe depression--a nationwide population-based study. |
70.00% |
|
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to... |
80.00% |
|
Independent Medicine - How to improve health by applying cheap, safe, and effective healing methods. |
100.00% |
|
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort |
80.00% |
|
Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain. |
|
|
Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain |
80.00% |
|
Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide. |
80.00% |
|
Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation. |
50.00% |
|
Inhibition of angiogenesis by non-toxic doses of temozolomide. |
50.00% |
|
Inhibition of angiogenesis of LCI-D20 hepatocellular carcinoma by metronomic chemotherapy of S-1 |
50.00% |
|
Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma. |
50.00% |
|
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. |
100.00% |
|
Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their de |
80.00% |
|
Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. |
50.00% |
|
Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angio.. |
60.00% |
|
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. |
70.00% |
|
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of m |
30.00% |
|
Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice |
80.00% |
|
Intravenous DMSO – Unsurpassable Results in Clinical Practice |
|
|
Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare |
60.00% |
|
Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen |
80.00% |
|
Is it time to test metformin in breast cancer clinical trials? |
90.00% |
|
IS THERE A COVID VACCINE / CANCER CONNECTION? |
100.00% |
|
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". |
60.00% |
|
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symp |
60.00% |
|
Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. |
70.00% |
|
IV Artesunate |
|
|
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. |
40.00% |
|
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. |
50.00% |
|
Local ultrasound hyperthermia as a component of radiotherapy for osteogenic sarcoma of tubular bones in children and adolescents |
70.00% |
|
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryother |
50.00% |
|
Long term outcomes following surgical resection of myxopapillary ependymomas. |
40.00% |
|
Long-term safety of BLP25 liposome vaccine (L-BLP25) in patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC). |
50.00% |
|
Low dose "Metronomic" Chemotherapy |
89.00% |
|
Low Dose naltrexone |
100.00% |
|
Low-dose methotrexate and cyclophosphamide in recurrent ovarian cancer. |
60.00% |
|
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts. |
70.00% |
|
Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast ca |
80.00% |
|
Low-dose naltrexone for disease prevention and quality of life. |
95.00% |
|
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid |
55.00% |
|
Medical Cannabis Compounds |
70.00% |
|
Melatonin |
45.00% |
|
Melatonin as biological response modifier in cancer patients. |
80.00% |
|
MET in small cell lung carcinoma (SCLC): Effects of a MET inhibitor in SCLC cell lines and prognostic role of MET status in pati |
50.00% |
|
Metabolic modulation of glioblastoma with dichloroacetate. |
90.00% |
|
Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy |
80.00% |
|
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. |
80.00% |
|
Metformin in the treatment of Cancer |
77.00% |
|
Metformin induces unique biological and molecular responses in triple negative breast cancer cells. |
80.00% |
|
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy. |
80.00% |
|
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission |
80.00% |
|
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. |
90.00% |
|
Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. |
60.00% |
|
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients .... |
80.00% |
|
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high... |
80.00% |
|
Metronomic chemotherapy: changing the paradigm that more is better. |
90.00% |
|
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. |
80.00% |
|
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti |
90.00% |
|
Metronomic Schedule of Paclitaxel Is Effective in Hormone Receptor–Positive and Hormone Receptor–Negative Breast Cancer |
80.00% |
|
Metronomic schedule of temozolomide with conventional dose of cisplatin in metastatic melanoma. Sub-category: Melanoma Categor |
90.00% |
|
Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. |
70.00% |
|
Mistletoe as a treatment for cancer. Has no proved benefit, and can cause harm |
20.00% |
|
Mistletoe in conventional oncological practice: exemplary cases. |
40.00% |
|
Mistletoe Therapy in Cancer |
83.33% |
|
Mistletoe therapy in oncology |
90.00% |
|
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. |
|
|
Modification of antinociceptive action of morphine by Ukrain in rodents |
50.00% |
|
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. |
80.00% |
|
Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain |
50.00% |
|
MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. |
90.00% |
|
Multicenter phase II study of temozolomide therapy for brain metastasis in patients with malignant melanoma, breast cancer...... |
60.00% |
|
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. |
100.00% |
